Circulation Heart Failure · 2015 · 42 citations · 25 references
MedicineCardiologyPharmacologyCell TherapyRegenerative MedicineStem Cell BiologyCardiac RegenerationStem Cell PhysiologyCardiac Cell EngraftmentCardiac Cell TherapyCardiac Progenitor CellsCardiac Stem CellsCell Dose DeterminationIntramyocardial Cell AdministrationMyocardial Infarction ModelsStem Cell Dose
BACKGROUND: Although c-kit(pos) cardiac stem cells (CSCs) preserve left ventricular (LV) function and structure after myocardial infarction, CSC doses have been chosen arbitrarily, and the dose-effect relationship is unknown. METHODS AND RESULTS: Rats underwent a 90-minute coronary occlusion followed by 35 days of reperfusion. Vehicle or CSCs at 5 escalating doses (0.3×10(6), 0.75×10(6), 1.5×10(6), 3.0×10(6), and 6.0×10(6) cells/heart) were given intracoronarily 4 h after reperfusion. The lowest dose (0.3×10(6)) had no effect on LV function and morphology, whereas 0.75, 1.5, and 3.0×10(6) significantly improved regional and global LV function (echocardiography and hemodynamic studies). These 3 doses had similar effects on echocardiographic parameters (infarct wall thickening fraction, LV end-systolic and end-diastolic volumes, LV ejection fraction) and hemodynamic variables (LV end-diastolic pressure, LV dP/dtmax, preload adjusted maximal power, end-systolic elastance, preload recruitable stroke work) and produced similar reductions in apoptosis, scar size, infarct wall thinning, and LV expansion index and similar increases in viable myocardium in the risk region (morphometry). Infusion of 6.0×10(6) CSCs markedly increased postprocedural mortality. Green fluorescent protein and 5-bromo-2'-deoxyuridine staining indicated that persistence of donor cells and formation of new myocytes were negligible with all doses. CONCLUSIONS: Surprisingly, in this rat model of acute myocardial infarction, the dose-response relationship for intracoronary CSCs is flat. A minimal dose between 0.3 and 0.75×10(6) is necessary for efficacy; above this threshold, a 4-fold increase in cell number does not produce greater improvement in LV function or structure. Further increases in cell dose are harmful.
25
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
Antonio Paolo Beltrami, Laura Barlucchi, Daniele Torella et al. · Cell · 2003 · 3.5K citations · Full text
Claudia Bearzi, Marcello Rota, Toru Hosoda et al. · Proceedings of the National Academy of Sciences · 2007 · 975 citations · Full text
Buddhadeb Dawn, Adam Stein, Konrad Urbanek et al. · Proceedings of the National Academy of Sciences · 2005 · 482 citations · Full text
Administration of Cardiac Stem Cells in Patients With Ischemic Cardiomyopathy: The SCIPIO Trial
Atul Chugh, Garth M. Beache, John Loughran et al. · Circulation · 2012 · 432 citations · Full text